Immatics (IMTX) FCF Margin Growth (1y) (2020 - 2025)
Immatics (IMTX) FCF Margin Growth (1y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Immatics |
14.67 Bn |
14.67 Bn |
- |
-12,036.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
-12,036.00 |
| Sep 30, 2025 |
-69,358.00 |
| Jun 30, 2025 |
-63,118.00 |
| Mar 31, 2025 |
-9,012.00 |
| Dec 31, 2024 |
-33,976.00 |
| Sep 30, 2024 |
25,812.00 |
| Jun 30, 2024 |
-18,139.00 |
| Mar 31, 2024 |
12,061.00 |
| Dec 31, 2023 |
27,594.00 |
| Sep 30, 2023 |
-25,422.00 |
| Jun 30, 2023 |
-26,750.00 |
| Mar 31, 2023 |
-30,350.00 |
| Dec 31, 2022 |
4,122.00 |
| Sep 30, 2022 |
18,276.00 |
| Jun 30, 2022 |
64,416.00 |
| Mar 31, 2022 |
32,285.00 |
| Dec 31, 2021 |
21,215.00 |
| Sep 30, 2021 |
5,707.00 |
| Jun 30, 2021 |
-15,313.00 |
| Mar 31, 2021 |
-8,856.00 |
